Global Bone Cement Market - 2024-2031
The global bone cement market reached US$ YY million in 2023 and is expected to reach US$ YY million by 2031, growing at a CAGR of YY% during the forecast period 2024-2031.
Bone cements are biomaterials created by combining a powder phase and a liquid phase, which may be molded and implanted as a paste and have the capacity to solidify once within the body. They are commonly employed in several types of orthopedic surgery. Bone cement is generally used to anchor artificial joints (e.g., knee, shoulder, and elbow joints) due to its moldability and simplicity of usage, assuring a precise fit between the bone and implant. It maintains strong bone-material interaction even in geometrically complicated flaws.
The most commonly used bone cement is an acrylate polymer called PMMA (Polymethylmethacrylate) and sometimes calcium phosphate is also used. The rising number of orthopedic surgeries and implant surgeries is a major factor driving the market growth in the forecast period.
Market Dynamics: DriversRising number of orthopedic surgeries
As the global population is rising, especially the old age demographic, orthopedic injuries are rising worldwide which is driving the demand for orthopedic surgeries. These orthopedic surgeries often involve implantation of bone grafts, joint arthroplasties, and fracture fixations, which use bone cement as a supporting material. Bone cement helps in maintanance of the structural integrity of the bone by acting as an anchor. With the rising number of orthopedic surgeries, the demand for bone cement is also expected to rise, parallelly causing the market growth in the forecast period.
As per OECD (Organization for Economic Cooperation and Development) statistics, the current global average number of hip replacement procedures is 172 per 100,000 population that makes upto 13 million surgeries. The current global average number of knee replacement procedures is 119 per 100,000 population, that makes upto 9.5 million surgeries.
As the global population is expected to rise, these number are projected to rise as well, concurrently propelling the market for bone cement. In addition, the rising technological advancements in the development of novel bone cement, and rising awareness and improved access to healthcare are the factors that are expected to drive the global bone cement market.
Restraints
The complications and risks associated with bone cement such as leakage, infection and allergic reactions may hinder the bone cement market. Moreover, the availability of alternative materials such as 3D printed implants, and bioabsorbable materials may lead to decreased use of traditional bone cement, which is another factor that may restrain the market growth in the forecast period.
For more details on this report - Request for Sample
Segment AnalysisThe global bone cement market is segmented based on type, application, end user, and region.
The acrylate polymers in the type segment accounted for approximately 73.30% of the global bone cement market share
Bone cement is a widely used biomaterial in orthopedic surgical procedures that helps in anchoring the implanted materials. This bone cement is usually made before or during the surgery by mixing powder and liquid components to form a dough-like consistent material that can be applied to the bone surface. There are currently two major bone cements used in surgeries: acrylate polymers and calcium phosphate.
Acrylate polymers especially PMMA (polymethylmethacrylate) is the most commonly employed bone cement. Due to its affordability, biocompatibility, and resilience, it is widely used in several orthopedic surgeries such as joint replacement, and as a bone filler and bone substitute. Moreover, antibiotics can be included in the PMMA mixture which is essential to prevent the incidence of infection. Due to its polymeric nature, it provides a prolonged release of antibiotics. Currently the research is being widely conducted to enhance the properties of PMMA as a bone cement.
For instance, in March 2024, a research study published in the Royal Society Open Science journal investigated the potential of fish bone material by incorporating nano fish bone and L-arginine protein into PMMA. The study has found enhancement of bone healing and tensile strength by these materials incorportated in PMMA as compared to traditional PMMA.
Moreover, in October 2023, a study published in Elsevier journal has stated that currently PMMA is the most widely used polymeric material bone cement in the vertebroplasty. Moreover, in sevral challenging orthopedic surgeries such as osteoporotic vertebral compression fractures, scoliosis, vertebral hemangiomas, spinal metastases, and myelomas, where it is vital in withstanding stress, PMMA is the bone material of choice.
Geographical AnalysisNorth America is expected to dominate the market with a 45.30% share in the global bone cement market
North America is expected to dominate the market due to its well-equipped healthcare facilities and specialty orthopedic centers. The number of orthopedic surgeries performed in the U.S. is far higher than in any other highly developed country. As per the American Academy of Orthopaedic Surgeons (AAOS) Registry, the cumulative number of joint replacement surgeries in the U.S. from 2012 to 2022 for 10 years is 3,149,042 including primary and revision hip and knee arthroplasty procedures. There will be approximately 598k new cases in 2022. The procedural volumes were growing at a compound annual growth rate of 23%.
Moreover, in the U.S. the shift of surgical procedures including joint arthroplasties from hospitals to ambulatory surgical centers (ASCs) has seen tremendous growth over the past decade. These ASCs are suited to provide affordable care to patients, which is anticipated to attract more and more patients in the upcoming years.
As per the annual report of the American Joint Replacement Registry published in 2023, the total joint arthroplasties in the outpatient setting has seen a huge growth in the past 10 years, reaching to 41,228 procedures till 2022.
Considering these procedure volumes, the demand for bone cement is concurrently high. In addition, the majority of the players in the market such as Stryker, Zimmer Biomet, Arthrex, Inc., and Heraeus Holding generate the majority of their revenue from the region. Any innovation by the market players tends to first get launched in the U.S. due to its stringent yet innovation-supporting regulatory policies. The investments by these companies and launches are majorly focussed in this region. These are the major factors which are expected to contribute to the region’s dominance in the global bone cement market.
Market SegmentationBy Type
• Calcium Phosphate
• Acrylic Cements
• Others
By Application
• Cranial Procedures
• Arthroplasty Procedures
• Implant Procedures
• Vertebroplasty
• Others
By End Users
• Hospitals & Clinics
• Orthopedic Centers
• Others
By Region
• North America
U.S.
Canada
Mexico
• Europe
Germany
U.K.
France
Spain
Italy
Rest of Europe
• South America
Brazil
Argentina
Rest of South America
• Asia-Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
• Middle East and Africa
Competitive LandscapeThe major players in the bone cement market include Stryker, Zimmer Biomet, Arthrex, Inc., Heraeus Holding, Cardinal Health., Medtronic, Exactech, Inc., OSARTIS GmbH, Tecres S.p.A. and Enovis Corporation among others.
Why Purchase the Report??
• To visualize the global bone cement market segmentation based on type, application, end-user, and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development
• Excel data sheet with numerous data points of bone cement market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.
The global bone cement market report would provide approximately 62 tables, 54 figures, and 187 Pages.
Target Audience 2024
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies